BMRN vs FIP · P/E 40, rev $1.76B vs rev $502.5M
Biomarin Pharmaceutical Inc (BMRN) versus FTAI Infrastructure Inc. (FIP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
FTAI Infrastructure Inc. (FIP) is a conglomerates company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported FIP revenue for 2025-12-31 was $502.5M. Net income was -$152.1M. Revenue was up 51.6% from 2024-12-31 to 2025-12-31. FIP currently screens at market cap $560.1M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. FIP currently screens at market cap $560.1M.
Not investment advice. Open the BMRN and FIP stock pages for the full models.
Not investment advice.